IBRN vs. EDOC
IBRN (iShares Neuroscience and Healthcare ETF) and EDOC (Global X Telemedicine & Digital Health ETF) are both Health & Biotech Equities funds - IBRN tracks the NYSE FactSet Global Neuro Biopharma and MedTech Index while EDOC tracks the Solactive Telemedicine & Digital Health Index- TR Net. Both are passively managed. Over the past 3 years, IBRN returned 14.57%/yr vs -8.61%/yr for EDOC. Their 0.58 correlation means they have sometimes moved together and sometimes differently. IBRN charges 0.47%/yr vs 0.68%/yr for EDOC.
Performance
IBRN vs. EDOC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IBRN achieves a 13.26% return, which is significantly higher than EDOC's -7.90% return.
IBRN
- 1D
- -3.24%
- 1M
- -6.28%
- 6M
- 12.31%
- YTD
- 13.26%
- 1Y
- 59.23%
- 3Y*
- 14.57%
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- 10.28%
EDOC
- 1D
- 0.07%
- 1M
- -7.11%
- 6M
- -5.44%
- YTD
- -7.90%
- 1Y
- -12.88%
- 3Y*
- -8.61%
- 5Y*
- -13.37%
- 10Y*
- —
- ALL TIME*
- -9.61%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $245.64K | $221.54K | $214.19K | |
| $83.61K | $123.63K | $97.37K |
IBRN vs. EDOC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
IBRN iShares Neuroscience and Healthcare ETF | 13.26% | 28.49% | -2.78% | 0.92% | 2.87% |
EDOC Global X Telemedicine & Digital Health ETF | -7.90% | -0.62% | -2.87% | -12.61% | -10.02% |
Correlation
The correlation between IBRN and EDOC is 0.47, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.47 |
Correlation (3Y) Balances recent behavior with more history. | 0.55 |
Correlation (All Time) Calculated using the full available price history since Aug 26, 2022 | 0.58 |
The correlation between IBRN and EDOC shifts across timeframes, from 0.47 (1 year) to 0.58 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IBRN vs. EDOC — Risk / Return Rank
IBRN
EDOC
IBRN vs. EDOC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Neuroscience and Healthcare ETF (IBRN) and Global X Telemedicine & Digital Health ETF (EDOC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IBRN | EDOC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.90 | ||
| Sortino ratioReturn per unit of downside risk | +3.86 | ||
| Omega ratioGain probability vs. loss probability | 1.36 | 0.92 | +0.44 |
| Calmar ratioReturn relative to maximum drawdown | 6.42 | -0.45 | +6.87 |
| Martin ratioReturn relative to average drawdown | 16.74 | -0.82 | +17.56 |
Loading charts...
Drawdowns
IBRN vs. EDOC - Drawdown Comparison
The maximum IBRN drawdown since its inception was -35.38%, smaller than the maximum EDOC drawdown of -65.76%. Use the drawdown chart below to compare losses from any high point for IBRN and EDOC.
Loading charts...
Drawdown Indicators
| IBRN | EDOC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -35.38% | -65.76% | +30.38% |
Max Drawdown (1Y)Largest decline over 1 year | -9.15% | -30.71% | +21.56% |
Max Drawdown (3Y)Largest decline over 3 years | -35.38% | -34.56% | -0.82% |
Max Drawdown (5Y)Largest decline over 5 years | — | -59.14% | — |
Current DrawdownCurrent decline from peak | -9.15% | -60.24% | +51.09% |
Average DrawdownAverage peak-to-trough decline | -9.59% | -43.48% | +33.89% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.50% | 16.87% | -13.37% |
Volatility
IBRN vs. EDOC - Volatility Comparison
iShares Neuroscience and Healthcare ETF (IBRN) has a higher volatility of 7.68% compared to Global X Telemedicine & Digital Health ETF (EDOC) at 6.34%. This indicates that IBRN's price experiences larger fluctuations and is considered to be riskier than EDOC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IBRN | EDOC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.68% | 6.34% | +1.34% |
Volatility (6M)Calculated over the trailing 6-month period | 19.64% | 17.24% | +2.40% |
Volatility (1Y)Calculated over the trailing 1-year period | 25.61% | 22.70% | +2.91% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 25.34% | 26.63% | -1.29% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.34% | 26.25% | -0.91% |
IBRN vs. EDOC - Expense Ratio Comparison
IBRN has a 0.47% expense ratio, which is lower than EDOC's 0.68% expense ratio.
Dividends
IBRN vs. EDOC - Dividend Comparison
IBRN's dividend yield for the trailing twelve months is around 0.87%, more than EDOC's 0.27% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
EDOC Global X Telemedicine & Digital Health ETF | 0.27% | 0.33% | 0.00% | 0.00% | 0.00% | 0.00% | 0.03% |
IBRN iShares Neuroscience and Healthcare ETF | 0.87% | 0.99% | 0.40% | 0.06% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
IBRN and EDOC have a correlation of 0.47, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IBRN has higher volatility (7.68%) compared to EDOC (6.34%). In terms of maximum drawdown, IBRN dropped -35.38% vs EDOC's -65.76%.
On 3-year performance, IBRN leads with 14.57% vs -8.61% for EDOC. On fees, IBRN is cheaper at 0.47% per year. On volatility, EDOC has been the lower-risk option at 6.34%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 3-year period, IBRN has performed better with a 14.57% return vs -8.61%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IBRN is cheaper with a 0.47% expense ratio, compared with 0.68% for EDOC.
IBRN has the higher dividend yield at 0.87%, compared with 0.27% for EDOC.
IBRN tracks NYSE FactSet Global Neuro Biopharma and MedTech Index, while EDOC tracks Solactive Telemedicine & Digital Health Index- TR Net. They also come from different issuers: iShares and Global X. Their fees differ too: 0.47% for IBRN and 0.68% for EDOC.
IBRN currently has the higher Sharpe Ratio (2.29 vs -0.61), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IBRN and EDOC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer